Literature DB >> 6725868

Bromocriptine-induced regression of a suprasellar extending prolactinoma during pregnancy.

T Bergh, S J Nillius, P Enoksson, L Wide.   

Abstract

A 21-year-old amenorrheic woman with hyperprolactinemia had rapid pituitary tumor enlargment during a bromocriptine-induced pregnancy. Before treatment the sella turcica was normal. In the 31st week of pregnancy she developed bitemporal hemianopsia and markedly decreased visual acuity. Computerized tomography showed a pituitary adenoma with suprasellar extension. Reinstitution of bromocriptine therapy resulted in rapid recovery of normal vision and radiologically verified tumor regression. Pregnancy continued to term and a healthy child was born. If pituitary tumor complications should occur during pregnancy, reinstitution of bromocriptine is the primary treatment of choice.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6725868     DOI: 10.1007/BF03348403

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  14 in total

1.  Prolactinoma: a question of rational treatment.

Authors:  C R Edwards; C M Feek
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-12

2.  Rapid regression of a suprasellar extending prolactinoma after bromocriptine treatment during pregnancy.

Authors:  E van Roon; J C van der Vijver; G Gerretsen; R E Hekster; R A Wattendorff
Journal:  Fertil Steril       Date:  1981-08       Impact factor: 7.329

3.  The incidence of complications during pregnancy after treatment of hyperprolactinemia with bromocriptine in patients with radiologically evident pituitary tumors.

Authors:  S W Lamberts; J G Klijn; S A de Lange; R Singh; S Z Stefanko; J C Birkenhäger
Journal:  Fertil Steril       Date:  1979-06       Impact factor: 7.329

4.  Growth of a prolactinoma during pregnancy. Case report and review.

Authors:  H B Dommerholt; J Assies; A J Van der Werf
Journal:  Br J Obstet Gynaecol       Date:  1981-01

5.  Surveillance of bromocriptine in pregnancy.

Authors:  I Turkalj; P Braun; P Krupp
Journal:  JAMA       Date:  1982-03-19       Impact factor: 56.272

Review 6.  Pituitary tumors and pregnancy.

Authors:  D M Magyar; J R Marshall
Journal:  Am J Obstet Gynecol       Date:  1978-12-01       Impact factor: 8.661

7.  Spontaneous and induced pregnancies in hyperprolactinemic women.

Authors:  P G Crosignani; C Ferrari; C Scarduelli; M C Picciotti; R Caldara; A Malinverni
Journal:  Obstet Gynecol       Date:  1981-12       Impact factor: 7.661

8.  A pregnancy in an acromegalic woman during bromocriptine treatment: effects on growth hormone and prolactin in the maternal, fetal, and amniotic compartments.

Authors:  M Bigazzi; R Ronga; I Lancranjan; S Ferraro; F Branconi; P Buzzoni; G Martorana; G F Scarselli; E Del Pozo
Journal:  J Clin Endocrinol Metab       Date:  1979-01       Impact factor: 5.958

9.  Acute visual loss during pregnancy after bromocriptine-induced ovulation. The elusive tumor.

Authors:  K A Burry; H S Schiller; R Mills; B Harris; L Heinrichs
Journal:  Obstet Gynecol       Date:  1978-07       Impact factor: 7.661

10.  Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumors.

Authors:  T Bergh; S J Nillius; L Wide
Journal:  Br Med J       Date:  1978-04-08
View more
  1 in total

Review 1.  Therapeutic applications of bromocriptine in endocrine and neurological diseases.

Authors:  K Y Ho; M O Thorner
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.